Since APOE ε4 allele carriage is considered the greatest non-modifiable risk factor for Alzheimer’s disease, this is an important confounding factor that should be evaluated in future studies, as a potential moderator of the relationship between PA and brain health (de Frutos-Lucas et al., 2020). This evidence concerns the gene APOE and early-onset autosomal dominant Alzheimer disease.